Design and rationale for a randomized, open-label, parallel clinical trial evaluating major adverse cardiovascular events (pharmacological treatment versus diet control) in patients with high-normal blood pressure: the PRINT-TAHA9 trial.
Armin AttarSeyed Alireza MirhosseiniRoham BorazjaniMehrab SayadiMahsa AhadiMohammadJavad ZibaeenezhadIman Razeghian-JahromiNader ParsaPublished in: Trials (2024)
The PRINT-TAHA9 trial was registered in October 2019 with the Iranian Registry of Clinical Trials (IRCT.ir) under the registration number IRCT20191002044961N1. https://irct.behdasht.gov.ir/trial/43092 .